These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28805577)

  • 1. Nonmotor Symptoms in Huntington Disease.
    Cardoso F
    Int Rev Neurobiol; 2017; 134():1397-1408. PubMed ID: 28805577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
    McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH;
    Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD.
    Honrath P; Dogan I; Wudarczyk O; Görlich KS; Votinov M; Werner CJ; Schumann B; Overbeck RT; Schulz JB; Landwehrmeyer BG; Gur RE; Habel U; Reetz K;
    J Neurol; 2018 Nov; 265(11):2548-2561. PubMed ID: 30167880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of behavioral manifestations of Huntington disease.
    van Duijn E
    Handb Clin Neurol; 2017; 144():129-139. PubMed ID: 28947111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal ideation in Huntington disease: the role of comorbidity.
    Wetzel HH; Gehl CR; Dellefave-Castillo L; Schiffman JF; Shannon KM; Paulsen JS;
    Psychiatry Res; 2011 Aug; 188(3):372-6. PubMed ID: 21605914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathology in verified Huntington's disease gene carriers.
    van Duijn E; Kingma EM; van der Mast RC
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):441-8. PubMed ID: 18070848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.
    Andrews SC; Langbehn DR; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC;
    Psychol Med; 2021 Jun; 51(8):1338-1344. PubMed ID: 32063235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatry of Huntington's disease and other basal ganglia disorders.
    Rosenblatt A; Leroi I
    Psychosomatics; 2000; 41(1):24-30. PubMed ID: 10665265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.
    Anderson KE; van Duijn E; Craufurd D; Drazinic C; Edmondson M; Goodman N; van Kammen D; Loy C; Priller J; Goodman LV
    J Huntingtons Dis; 2018; 7(3):355-366. PubMed ID: 30040737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease.
    Wesson M; Boileau NR; Perlmutter JS; Paulsen JS; Barton SK; McCormack MK; Carlozzi NE
    J Huntingtons Dis; 2018; 7(3):239-249. PubMed ID: 30056431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral changes in Huntington Disease.
    Craufurd D; Thompson JC; Snowden JS
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(4):219-26. PubMed ID: 11725215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Correlates of Depression and Suicidality in Huntington Disease: An Analysis of the Enroll-HD Observational Study.
    Rocha NP; Tuazon MR; Patino J; Furr Stimming E; Teixeira AL
    Cogn Behav Neurol; 2022 Jun; 35(2):85-94. PubMed ID: 35486527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
    Thompson JC; Harris J; Sollom AC; Stopford CL; Howard E; Snowden JS; Craufurd D
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):53-60. PubMed ID: 22450614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is non-recognition of choreic movements in Huntington disease always pathological?
    Justo D; Charles P; Daunizeau J; Delmaire C; Gargiulo M; Hahn-Barma V; Naccache L; Durr A
    Neuropsychologia; 2013 Mar; 51(4):748-59. PubMed ID: 23262076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and behavioral changes in Huntington disease before diagnosis.
    Paulsen JS; Miller AC; Hayes T; Shaw E
    Handb Clin Neurol; 2017; 144():69-91. PubMed ID: 28947127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychopharmacology of Huntington disease.
    Petersén Å; Weydt P
    Handb Clin Neurol; 2019; 165():179-189. PubMed ID: 31727211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.